SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Emergent BioSolutions Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
Werte in diesem Artikel
NEW YORK, Aug. 8, 2023 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Emergent BioSolutions Inc. (NYSE: EBS).
If you are a shareholder of Emergent BioSolutions Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: https://pjlfirm.com/emergent-biosolutions-inc/
You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.
Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Purcell & Lefkowitz LLP
Ausgewählte Hebelprodukte auf Emergent BioSolutions
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Emergent BioSolutions
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Emergent BioSolutions Aktie News
Emergent BioSolutions Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Emergent BioSolutions nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.08.18 | Emergent BioSolutions Buy | Chardan Capital Markets | |
| 16.01.18 | Emergent BioSolutions Buy | Chardan Capital Markets | |
| 28.06.16 | Emergent BioSolutions Buy | Singular Research | |
| 15.04.16 | Emergent BioSolutions Buy | Chardan Capital Markets | |
| 28.03.16 | Emergent BioSolutions Buy | Singular Research |